The U.S. Food and Drug Administration (FDA) is reviewing a new flu vaccine for adults age 50 and older. If approved, it would be the first influenza shot to use mRNA technology, and experts say it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results